DALLA PALMA, ANNA BENEDETTA
 Distribuzione geografica
Continente #
NA - Nord America 510
EU - Europa 422
AS - Asia 142
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 1.080
Nazione #
US - Stati Uniti d'America 500
SE - Svezia 127
CN - Cina 104
IE - Irlanda 94
IT - Italia 80
DE - Germania 32
SG - Singapore 19
AT - Austria 15
FR - Francia 15
TR - Turchia 14
FI - Finlandia 13
RO - Romania 12
CZ - Repubblica Ceca 10
CA - Canada 9
BE - Belgio 8
GB - Regno Unito 5
IN - India 4
SC - Seychelles 3
UA - Ucraina 3
EU - Europa 2
NL - Olanda 2
RU - Federazione Russa 2
BG - Bulgaria 1
BZ - Belize 1
KH - Cambogia 1
LU - Lussemburgo 1
NG - Nigeria 1
NO - Norvegia 1
RS - Serbia 1
Totale 1.080
Città #
Chandler 132
Dublin 94
Ann Arbor 57
Ashburn 52
Shanghai 36
New York 26
Beijing 21
Dearborn 19
Parma 19
Boardman 17
Bremen 16
Princeton 16
Vienna 15
Wilmington 13
Izmir 12
Helsinki 10
Nanjing 10
Brno 8
Brussels 8
Singapore 8
Des Moines 7
San Mateo 7
Fairfield 6
Focsani 6
Romainville 6
Shenyang 6
Toronto 6
Woodbridge 6
Bologna 5
Modena 5
Munich 4
Rho 4
Savignano sul Rubicone 4
West Jordan 4
Cesena 3
Guangzhou 3
Hangzhou 3
Hebei 3
Jinan 3
Los Angeles 3
Milan 3
Nanchang 3
Norwalk 3
Reggio Emilia 3
Rome 3
Seattle 3
Arcevia 2
Borås 2
Changsha 2
Cornaredo 2
Florence 2
Fremont 2
Jacksonville 2
Kocaeli 2
Marseille 2
Ottawa 2
Piacenza 2
Pune 2
Santa Clara 2
Taiyuan 2
Tianjin 2
Washington 2
Amsterdam 1
Aosta 1
Augusta 1
Belgrade 1
Belize City 1
Castelfranci 1
Castelfranco Emilia 1
Charlotte 1
Chengdu 1
Denver 1
Edinburgh 1
Hefei 1
Huizen 1
Jiaxing 1
Kunming 1
Lagos 1
Leawood 1
Lille 1
Luxembourg 1
Manchester 1
Monmouth Junction 1
Montesilvano 1
Naples 1
Nerviano 1
Oslo 1
Paris 1
Phnom Penh 1
Phoenix 1
Rockville 1
Sofia 1
Taizhou 1
Tampa 1
Turku 1
Verona 1
Wuhan 1
Zhengzhou 1
Totale 769
Nome #
Neurofibromatosis type I and multiple myeloma coexistence: A possible link? 90
Bone marrow CX3CL1/Fractalkine is a new player of the pro-angiogenic microenvironment in multiple myeloma patients 87
Novel targets for the treatment of relapsing multiple myeloma 78
Bovine pestivirus is a new alternative virus for multiple myeloma oncolytic virotherapy 76
CD14+CD16+ monocytes are involved in daratumumab-mediated myeloma cells killing and in anti-CD47 therapeutic strategy 75
Bone Marrow DKK-1 Levels in Smoldering Multiple Myeloma Patients: A New Independent Risk Factor for Progression 73
A Rare Case of Systemic AL Amyloidosis with Muscle Involvement: A Misleading Diagnosis 67
PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma Patients 66
Myeloma Cells Deplete Bone Marrow Glutamine and Inhibit Osteoblast Differentiation Limiting Asparagine Availability 65
Monoclonal and Bispecific Anti-BCMA Antibodies in Multiple Myeloma 55
Lenalidomide Increases Human Dendritic Cell Maturation in Multiple Myeloma Modulating Both Monocyte Differentiation and Mesenchymal Stromal Cell Inhibitory Properties through Ikaros and Casein Kinase 1 Degradation, Respectively 55
CD38 Expression by Myeloma Cells and Its Role in the Context of Bone Marrow Microenvironment: Modulation by Therapeutic Agents 52
Concomitant primary hyperparathyroidism in patients with multiple myeloma: A possible link? 51
Novel Approaches to Improve Myeloma Cell Killing by Monoclonal Antibodies 49
Phase II Trial of Maintenance Treatment With IL2 and Zoledronate in Multiple Myeloma After Bone Marrow Transplantation: Biological and Clinical Results 48
Combining bortezomib to high dose melphalan as conditioning regimen results in the improvement of the response rate in newly diagnosed young multiple myeloma patients 48
The impact of CD56 expression in smoldering myeloma patients on early progression 35
Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response 20
T(10;11)(P13;P14-21) PICALM-MLLT10 ACUTE LEUKEMIA: CHARACTERIZATION OF TWO CASES WITH DIFFERENT PHENOTYPIC PRESENTATION 10
Identification of PSMB4 and PSMD4 as novel target genes correlated with 1q21 amplification in patients with smoldering myeloma and multiple myeloma 9
CD38 expression by plasma cells in extramedullary multiple myeloma 9
PROGNOSTIC VALUE OF CYTOGENETIC ABERRATIONS AND INTRATUMORAL GENETIC HETEROGENEITY IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) 8
Totale 1.126
Categoria #
all - tutte 5.063
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.063


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020106 11 5 2 3 7 18 13 2 20 18 5 2
2020/2021125 4 3 6 3 29 3 12 13 14 14 9 15
2021/2022134 2 5 9 12 1 2 26 18 6 3 12 38
2022/2023482 62 58 36 42 42 48 24 21 109 11 18 11
2023/2024235 8 17 3 4 22 71 19 7 6 14 19 45
2024/20255 5 0 0 0 0 0 0 0 0 0 0 0
Totale 1.126